INX-315
INX-315 is a selective, orally bioavailable CDK2 inhibitor. It demonstrates anticancer activity by inducing cell cycle arrest, senescence, and suppressing E2F-driven transcription, validated in models of CCNE1-amplified cancers and CDK4/6 inhibitor-resistant breast cancer.
Product Specifications
CAS Number
2745060-92-6
Field of Research
Cell Biology
Purity
99.88% (May vary between batches)
Solubility
DMSO:80 mg/mL (187.14 mM) ;10% DMSO+40% PEG300+5% Tween-80+45% Saline:3.3 mg/mL (7.72 mM)
Smiles
O=C1NNC2=CC=3C=NC (=NC3N2C14CCCCC4) NC5=CC=C (C=C5) S (=O) (=O) N
Molecular Formula
C19H21N7O3S
Molecular Weight
427.48
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
36607121 3x 1.0µg DNA
PHLPP1 CRISPRa sgRNA lentivector (set of three targets)(Human)
Sign In for Pricing
View Details 
![4-[2- (4-Chlorophenyl) -1,3-thiazol-4-yl]piperidine](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
MKD56127-01 50 mg
4-[2- (4-Chlorophenyl) -1,3-thiazol-4-yl]piperidine
Sign In for Pricing
View Details ![4-[2- (4-Chlorophenyl) -1,3-thiazol-4-yl]piperidine](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
MKD56127-02 0.5 g
4-[2- (4-Chlorophenyl) -1,3-thiazol-4-yl]piperidine
Sign In for Pricing
View Details